Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DocGo Inc. Director's Dealing 2022

Apr 26, 2022

33981_dirs_2022-04-26_5bf842dc-5ad2-409b-996f-8d13b72c32d2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DocGo Inc. (DCGO)
CIK: 0001822359
Period of Report: 2022-03-28

Reporting Person: Bienstock Lee (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-28 Restricted Stock Unit A 146853 $0.00 Acquired 146853 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-28 Option to Buy $7.15 A 320122 Acquired Common stock (320122) Direct
2022-03-28 Option to Buy $7.15 A 100000 Acquired Common stock (100000) Direct

Footnotes

F1: Mr. Bienstock was granted 146,853 restricted stock units on March 28, 2022 pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan")., vesting 25% on each of March 28, 2023, March 28, 2024, March 28, 2025 and March 28, 2026. Each restricted stock unit represents the right to receive, upon vesting, one share of Common Stock.

F2: Mr. Bienstock was granted 320,122 options on March 28, 2022 pursuant to the Plan, vesting 25% on each of March 28, 2023, March 28, 2024, March 28, 2025 and March 28, 2026, in each case, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock.

F3: Mr. Bienstock was granted 100,000 options on March 28, 2022 pursuant to the Plan, vesting 100% on March 28, 2023, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock.